As every bodybuilder knows, a deep, restful sleep boosts levels of growth hormone to build strong muscle and bone and burn fat. And as every teenager should know, they won't reach their full height potential without adequate growth hormone from a full night's sleep.

But why lack of sleep -- in particular the early, deep phase called non-REM sleep -- lowers levels of growth hormone has been a mystery.

In a study published in the current issue of the journal Cell, researchers from University of California, Berkeley, dissect the brain circuits that control growth hormone release during sleep and report a novel feedback mechanism in the brain that keeps growth hormone levels finely balanced.

The findings provide a map for understanding how sleep and hormone regulation interact. The new feedback mechanism could open avenues for treating people with sleep disorders tied to metabolic conditions like diabetes, as well as degenerative diseases like Parkinson's and Alzheimer's.

"People know that growth hormone release is tightly related to sleep, but only through drawing blood and checking growth hormone levels during sleep," said study first author Xinlu Ding, a postdoctoral fellow in UC Berkeley's Department of Neuroscience and the Helen Wills Neuroscience Institute. "We're actually directly recording neural activity in mice to see what's going on. We are providing a basic circuit to work on in the future to develop different treatments."

Because growth hormone regulates glucose and fat metabolism, insufficient sleep can also worsen risks for obesity, diabetes and cardiovascular disease.

The sleep-wake cycle

The neurons that orchestrate growth hormone release during the sleep-wake cycle -- growth hormone releasing hormone (GHRH) neurons and two types of somatostatin neurons -- are buried deep in the hypothalamus, an ancient brain hub conserved in all mammals. Once released, growth hormone increases the activity of neurons in the locus coeruleus, an area in the brainstem involved in arousal, attention, cognition and novelty seeking. Dysregulation of locus coeruleus neurons is implicated in numerous psychiatric and neurological disorders.

"Understanding the neural circuit for growth hormone release could eventually point toward new hormonal therapies to improve sleep quality or restore normal growth hormone balance," said Daniel Silverman, a UC Berkeley postdoctoral fellow and study co-author. "There are some experimental gene therapies where you target a specific cell type. This circuit could be a novel handle to try to dial back the excitability of the locus coeruleus, which hasn't been talked about before."

The researchers, working in the lab of Yang Dan, a professor of neuroscience and of molecular and cell biology, explored the neuroendocrine circuit by inserting electrodes in the brains of mice and measuring changes in activity after stimulating neurons in the hypothalamus with light. Mice sleep for short periods -- several minutes at a time -- throughout the day and night, providing many opportunities to study growth hormone changes during sleep-wake cycles.

Using state-of-the-art circuit tracing, the team found that the two small-peptide hormones that control the release of growth hormone in the brain -- GHRH, which promotes release, and somatostatin, which inhibits release -- operate differently during REM and non-REM sleep. Somatostatin and GHRH surge during REM sleep to boost growth hormone, but somatostatin decreases and GHRH increases only moderately during non-REM sleep to boost growth hormone.

Released growth hormone regulates locus coeruleus activity, as a feedback mechanism to help create a homeostatic yin-yang effect. During sleep, growth hormone slowly accumulates to stimulate the locus coeruleus and promote wakefulness, the new study found. But when the locus coeruleus becomes overexcited, it paradoxically promotes sleepiness, as Silverman showed in a study published earlier this year.

"This suggests that sleep and growth hormone form a tightly balanced system: Too little sleep reduces growth hormone release, and too much growth hormone can in turn push the brain toward wakefulness," Silverman said. "Sleep drives growth hormone release, and growth hormone feeds back to regulate wakefulness, and this balance is essential for growth, repair and metabolic health."

Because growth hormone acts in part through the locus coeruleus, which governs overall brain arousal during wakefulness, a proper balance could have a broader impact on attention and thinking.

"Growth hormone not only helps you build your muscle and bones and reduce your fat tissue, but may also have cognitive benefits, promoting your overall arousal level when you wake up," Ding said.

The work was funded by the Howard Hughes Medical Institute (HHMI), which until this year supported Dan as an HHMI investigator, and the Pivotal Life Sciences Chancellor's Chair fund. Dan is the Pivotal Life Sciences Chancellor's Chair in Neuroscience. Other co-authors of the paper are Peng Zhong, Bing Li, Chenyan Ma, Lihui Lu, Grace Jiang, Zhe Zhang, Xiaolin Huang, Xun Tu and Zhiyu Melissa Tian of UC Berkeley; and Fuu-Jiun Hwang and Jun Ding of Stanford University.

Read more …The sleep switch that builds muscle, burns fat, and boosts brainpower

Date:
Source:
Universität Leipzig
Summary:
Scientists at Leipzig University have identified a little-known receptor, GPR133, as a key player in bone health. By stimulating this receptor with a new compound called AP503, they were able to boost bone strength in mice, even reversing osteoporosis-like conditions. The breakthrough highlights a promising path toward safer and more effective treatments for millions struggling with bone loss, while also hinting at broader benefits for aging populations.

FULL STORY


A Way to Strengthen Bones for Life
A new receptor target, GPR133, shows major promise for reversing bone loss and fighting osteoporosis. Credit: Shutterstock

There is a high demand for safe and long-lasting medications to treat bone loss, known medically as osteoporosis. In Germany, around six million people - mostly women - are affected by this widespread condition. Discovering new targets for drug development is therefore a key step towards better therapies with fewer side effects. The adhesion G protein-coupled receptor GPR133 belongs to a still relatively unexplored group of receptors. In a recent study, scientists at Leipzig University demonstrated that GPR133 plays a central role in building and maintaining healthy bone.

"If this receptor is impaired by genetic changes, mice show signs of loss of bone density at an early age - similar to osteoporosis in humans. Using the substance AP503, which was only recently identified via a computer-assisted screen as a stimulator of GPR133, we were able to significantly increase bone strength in both healthy and osteoporotic mice," explains Professor Ines Liebscher, lead investigator of the study from the Rudolf Schönheimer Institute of Biochemistry at the Faculty of Medicine.

In bone tissue, GPR133 is activated through the interaction of neighboring bone cells and mechanical strain. This triggers a signal that stimulates bone-forming cells (osteoblasts) and inhibits bone-resorbing cells (osteoclasts). The result: stronger, more resilient bones. The new active substance AP503 can mimic this natural activation. In the future, it could be used both to further strengthen healthy bones and to rebuild weakened ones - for instance, in cases of osteoporosis in women going through menopause.

Great potential for an aging population

In an earlier study, researchers at Leipzig University had already found that activation with AP503 also strengthens skeletal muscle. "The newly demonstrated parallel strengthening of bone once again highlights the great potential this receptor holds for medical applications in an aging population," says Dr Juliane Lehmann, lead author of the study and a researcher at the Rudolf Schönheimer Institute of Biochemistry. The Leipzig research team is already working on several follow-up projects to explore the use of AP503 in various diseases and to further investigate the role of GPR133 in the body.

Background

For more than ten years, the study of adhesion G protein-coupled receptors has been a key focus at Leipzig University within Collaborative Research Centre 1423, Structural Dynamics of GPCR Activation and Signaling. Internationally, Leipzig is regarded as a leading center in this field of research.


Story Source:

Materials[1] provided by Universität Leipzig. Note: Content may be edited for style and length.


Journal Reference:

  1. Juliane Lehmann, Hui Lin, Zihao Zhang, Maren Wiermann, Albert M. Ricken, Franziska Brinkmann, Jana Brendler, Christian Ullmann, Luisa Bayer, Sandra Berndt, Anja Penk, Nadine Winkler, Franz Wolfgang Hirsch, Thomas Fuhs, Josef Käs, Peng Xiao, Torsten Schöneberg, Martina Rauner, Jin-Peng Sun, Ines Liebscher. The mechanosensitive adhesion G protein-coupled receptor 133 (GPR133/ADGRD1) enhances bone formation. Signal Transduction and Targeted Therapy, 2025; 10 (1) DOI: 10.1038/s41392-025-02291-y[2]

Cite This Page:

Universität Leipzig. "Scientists may have found a way to strengthen bones for life." ScienceDaily. ScienceDaily, 8 September 2025. <www.sciencedaily.com/releases/2025/09/250908175438.htm>.

Universität Leipzig. (2025, September 8). Scientists may have found a way to strengthen bones for life. ScienceDaily. Retrieved September 8, 2025 from www.sciencedaily.com/releases/2025/09/250908175438.htm

Universität Leipzig. "Scientists may have found a way to strengthen bones for life." ScienceDaily. www.sciencedaily.com/releases/2025/09/250908175438.htm (accessed September 8, 2025).

RELATED STORIES


High Muscle Strength Linked to Lower Risk of Type 2 Diabetes[3]

Apr. 8, 2025 — Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk. ...

Neurotherapeutic to Address Muscle Weakness[4]

Mar. 5, 2025 — While a gradual loss in muscle strength is a natural part of aging, for many older adults it's more than just feeling a little weaker. Sarcopenia -- a condition affecting nearly half of adults ...

Strength Gain Is Associated With Training Volume in Low Responders[5]

Nov. 16, 2022 — High-intensity isometric training is considered to be important in achieving greater strength gain. Recent study has shown that training volume is more important for strength gain than training ...

High Blood Pressure May Accelerate Bone Aging[6]

Sep. 7, 2022 — A new study in mice found that hypertension may be linked to significant bone loss. Bone quality in young mice with high blood pressure was similar to the bones of older mice without high blood ...

Unlocking the Mystery Behind Skeletal Aging[7]

Feb. 16, 2021 — Researchers have identified the role a critical enzyme plays in skeletal aging and bone loss, putting them one step closer to understanding the complex biological mechanisms that lead to ...

Stronger Bones Thanks to Heat and Microbiota[8]

Sep. 11, 2020 — Osteoporosis is characterized by a deterioration of the bones and an increased risk of fractures. With one third of postmenopausal women affected, it is a major public health problem. A research team ...

TRENDING AT SCITECHDAILY.com[9]


Plant Waste? The Surprising Secret Ingredient Making Concrete Stronger and Greener[10]

A New Weapon Against Cancer: Cold Plasma Destroys Hidden Tumor Cells[11]

Starving Cancer: New Diet Slows Growth of Deadliest Brain Tumors in Mice[12]

Weight-Loss Drug Mounjaro Shrinks Breast Cancer Tumors in Mice[13]

Read more …Scientists may have found a way to strengthen bones for life

Date:
Source:
University of Nottingham
Summary:
Researchers have uncovered why older adults are more vulnerable to severe flu. The culprit is a protein called ApoD, which rises with age and disrupts the body’s ability to fight infection. This protein damages lung tissue and weakens immune defenses, leading to worse outcomes. By pinpointing ApoD as the driver, scientists now see a promising new treatment target that could protect elderly patients from life-threatening influenza and dramatically cut flu-related deaths.

FULL STORY


Why the Flu Turns Deadly for Older Adults
A single protein, ApoD, may explain why flu is deadlier for the elderly—and could be the key to future treatments. Credit: Shutterstock

Scientists have discovered why older people are more likely to suffer severely from the flu, and can now use their findings to address this risk.

In a new study, which is published in PNAS, experts discovered that older people produce a glycosylated protein called apoplipoprotein D (ApoD), which is involved in lipid metabolism and inflammation, at much higher levels than in younger people. This has the effect of reducing the patient's ability to resist virus infection, resulting in a more serious disease outcome.

The team established that highly elevated ApoD production with age in the lung drives extensive tissue damage during infection to reduce the protective antiviral type I interferon response.

The research was an international collaboration led by scientists from the China Agricultural University, University of Notttingham, Institute of Microbiology (Chinese Academy of Sciences), National Institute for Viral Disease Control and Prevention (Chinese Centre for Disease Control and Prevention) and the University of Edinburgh.

"Aging is a leading risk factor in influenza-related deaths. Furthermore, the global population is aging at an unprecedented rate in human history, posing major issues for healthcare and the economy. So we need to find out why older patients often suffer more severely from influenza virus infection," says Professor Kin-Chow Chang from the School of Veterinary Medicine and Science at the University of Nottingham, and co-author on the paper.

In this new study, the team investigated the mechanisms behind increased severity of influenza virus infection with age using an aging-mouse model and appropriate donor human tissue sections.

They identified ApoD as an age-related cell factor that impairs the activation of the immune system's antiviral response to influenza virus infection by causing extensive breakdown of mitochondria (mitophagy) resulting in greater production of virus and lung damage during infection. Mitochondria are essential for cellular production of energy and for induction of protective interferons.

ApoD is therefore a target for therapeutic intervention to protect against severe influenza virus infection in the elderly which would have a major impact on reducing morbidity and mortality in the aging population.

Professor Chang, added: "There is now an exciting opportunity to therapeutically ameliorate disease severity of the elderly from influenza virus infection by the inhibitory targeting of ApoD."


Story Source:

Materials provided by University of Nottingham. Note: Content may be edited for style and length.


Cite This Page:

University of Nottingham. "Why the flu turns deadly for older adults, and how scientists found the cause." ScienceDaily. ScienceDaily, 8 September 2025. <www.sciencedaily.com/releases/2025/09/250908175434.htm>.

University of Nottingham. (2025, September 8). Why the flu turns deadly for older adults, and how scientists found the cause. ScienceDaily. Retrieved September 8, 2025 from www.sciencedaily.com/releases/2025/09/250908175434.htm

University of Nottingham. "Why the flu turns deadly for older adults, and how scientists found the cause." ScienceDaily. www.sciencedaily.com/releases/2025/09/250908175434.htm (accessed September 8, 2025).

RELATED STORIES


Fat-Rich Fluid Fuels Immune Failure in Ovarian Cancer[1]

May 9, 2025 — New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...

Simple Test for Flu Could Improve Diagnosis and Surveillance[2]

June 21, 2024 — Fewer than one percent of people who get the flu every year get tested, in part because most tests require trained personnel and expensive equipment. Now researchers have developed a low-cost paper ...

New Study Finds Blocking Histones Using Antibodies Alleviated Lung Fibrosis[3]

Sep. 27, 2023 — Lung fibrosis is a debilitating disease affecting nearly 250,000 people in the U.S. alone with 50,000 new cases reported each year. There is currently no cure and limited available treatment options, ...

Discovery Could Lead to Better Cancer Immunotherapy[4]

May 31, 2022 — A type of white blood cell previously known only as a helper in the immune system appears also to be the instigator of the body's defenses against cancerous tumors. The discovery could lead to ...

Lung Tissue from the Lab[5]

Mar. 18, 2022 — An international research team has found a simple method for growing lung tissue in the lab. These organoids could be used in diagnosis, drug development, and fundamental research. Laboratory studies ...

Researchers Find Surprising Benefit to the Immune System Following Infection[6]

Dec. 3, 2021 — The human body's immune system weakens over time, making older adults more susceptible to infections and leaving scientists with the puzzling dilemma of how to maintain health across the ...

TRENDING AT SCITECHDAILY.com[7]


Plant Waste? The Surprising Secret Ingredient Making Concrete Stronger and Greener[8]

A New Weapon Against Cancer: Cold Plasma Destroys Hidden Tumor Cells[9]

Starving Cancer: New Diet Slows Growth of Deadliest Brain Tumors in Mice[10]

Weight-Loss Drug Mounjaro Shrinks Breast Cancer Tumors in Mice[11]

Read more …Why the flu turns deadly for older adults, and how scientists found the cause

In northern California, salmon are more than just fish -- they're a cornerstone of tribal traditions, a driver of tourism and a sign of healthy rivers. So it may not come as a surprise that NAU and University of California Berkeley scientists working along the region's Eel River have discovered a micro-scale nutrient factory that keeps rivers healthy and allows salmon to thrive.

The scientists' new study in Proceedings of the National Academy of Sciences (PNAS) reveals how a partnership between algae and bacteria works like nature's clean-nitrogen machine, turning nitrogen from the air into food that fuels river ecosystems without fertilizers or pollution. The hidden nutrient factory boosts populations of aquatic insects, which young salmon rely on for growth and survival.

At the heart of the scientists' discovery is a type of diatom -- a single-celled aquatic plant in a glass-like shell -- called Epithemia. The golden-brown diatom, smaller than a grain of table salt and approximately the width of a human hair, plays a massive role in keeping rivers productive. Inside each diatom live bacterial partners housed within the cell called diazoplasts -- tiny nitrogen-fixing compartments that transform air into plant food. The diatom Epithemia captures sunlight and makes sugar, which the diazoplast uses to turn atmospheric nitrogen into a nutrient form. In return, the diazoplast provides nitrogen that helps the diatom keep photosynthesizing.

"This is nature's version of a clean nutrient pipeline, from sunlight to fish, without the runoff that creates harmful algal blooms," said Jane Marks, biology professor at Northern Arizona University and lead author of the study.

By late summer, Marks said, strands of the green alga Cladophora are draped with rusty-red Epithemia along the Eel River. At this stage, the algae-bacteria duos supply up to 90% of the new nitrogen entering the river's food web, giving insect grazers the fuel they need and powering salmon from the bottom up.

"Healthy rivers don't just happen -- they're maintained by ecological interactions, like this partnership," said Mary Power, co-author of the study and faculty director of UC Berkeley's Angelo Coast Range Reserve, where the field study took place. "When native species thrive in healthy food webs, rivers deliver clean water, wildlife and essential support for fishing and outdoor communities."

Using advanced imaging, the research team watched the partners trade life's essentials in a perfect loop: The diatom used sunlight and carbon dioxide to make sugar and share it with the bacterium, which then used the sugar to turn nitrogen from the air into plant food. That nitrogen helped the diatom make even more sugar, because the key enzymes of photosynthesis need lots of nitrogen.

"It's like a handshake deal: Both sides benefit, and the entire river thrives," said Mike Zampini, a postdoctoral researcher at NAU and the study's isotope tracing lead. "The result is a beautifully efficient cycle of energy and nutrients."

This partnership isn't unique to the Eel River. Epithemia and similar diatom-diazoplast teams live in rivers, lakes and oceans across the world, often in places where nitrogen is scarce. That means they may be quietly boosting productivity in many other ecosystems.

Beyond its role in nature, this clean and efficient nutrient exchange could inspire new technologies such as more efficient biofuels, natural fertilizers that don't pollute or even crop plants engineered to make their own nitrogen, cutting costs for farmers while reducing environmental impacts.

When nature engineers solutions this elegant, Marks said, it reminds us what's possible when people, places and discovery come together.

Other researchers involved in the study included NAU faculty Bruce Hungate and Egbert Schwartz, staff members Michael Wulf and Victor Leshyk and graduate students Raina Fitzpatrick and Saeed Kariunga; University of Alabama professor Steven Thomas and graduate student Augustine Sitati; and Lawrence Livermore National Laboratory researchers Ty Samo, Peter Weber, Christina Ramon and Jennifer Pett-Ridge. The research was funded in part by a grant from the National Science Foundation's Rules of Life/Microbiome program (#2125088). Research at Lawrence Livermore National Labs was conducted under U.S. Department of Energy Contract DE-AC52-07NA27344.

Read more …Salmon’s secret superfood is smaller than a grain of salt

More Articles …